This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
[P4–552]: AN ANALYTICAL FRAMEWORK TO PROJECT THE POTENTIAL MEDICARE COST BENEFIT OF INTEPIRDINE (RVT101) IN MILD‐MODERATE ALZHEIMER'S DISEASE. (1st July 2017)
Record Type:
Journal Article
Title:
[P4–552]: AN ANALYTICAL FRAMEWORK TO PROJECT THE POTENTIAL MEDICARE COST BENEFIT OF INTEPIRDINE (RVT101) IN MILD‐MODERATE ALZHEIMER'S DISEASE. (1st July 2017)
Main Title:
[P4–552]: AN ANALYTICAL FRAMEWORK TO PROJECT THE POTENTIAL MEDICARE COST BENEFIT OF INTEPIRDINE (RVT101) IN MILD‐MODERATE ALZHEIMER'S DISEASE